Investigating the poor outcomes ofBRAF-mutant advanced colorectal cancer: analysis from 2530 patients in randomised clinical trialsJenny F. Seligmann, Gary Middleton, Christopher G. Smith et al.|Annals of Oncology|2016Cited by 165
Combined Epiregulin and Amphiregulin Expression Levels as a Predictive Biomarker for Panitumumab Therapy Benefit or Lack of Benefit in Patients With<i>RAS</i>Wild-Type Advanced Colorectal CancerJenny F. Seligmann, Michel Seymour, Faye Elliott et al.|JAMA Oncology|2016Cited by 115
Targeting human apurinic/apyrimidinic endonuclease 1 (APE1) in phosphatase and tensin homolog (PTEN) deficient melanoma cells for personalized therapyRachel Abbotts, Srinivasan Madhusudan, Rosalyn Jewell et al.|Oncotarget|2014Cited by 51
Association of Tumor <i>HER3</i> Messenger RNA Expression With Panitumumab Efficacy in Advanced Colorectal CancerJenny F. Seligmann, Michel Seymour, Ace J. Hatch et al.|JAMA Oncology|2017Cited by 29
Association of Melanocortin-1 Receptor Variants with Pigmentary Traits in Humans: A Pooled Analysis from the M-Skip ProjectElena Tagliabue, Eduardo Nagore, Sara Gandini et al.|Journal of Investigative Dermatology|2016Cited by 20